Navigation Links
ImmunoVaccine Technologies Receives $3 Million From ACOA
Date:1/21/2008

HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a clinical stage vaccine development company, will receive $3 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF). This funding will enable IVT to undertake a $6 million project to develop new potent immune enhancement systems.

"Having ACOA recognize the market potential of our innovative vaccine platform is a tremendous boost," commented Brian Lowe, Vice President of IVT. "This funding will enable us, over the next three years, to create novel vaccines for the treatment of cancer and infectious diseases.

This funding announcement is the maximum grant awarded to a private company under Round V of the AIF. The funds will further IVT's research collaborations and commercialization opportunities with pharmaceutical companies worldwide.

Atlantic Innovation Fund investments were announced earlier today by The Honourable Peter MacKay, Minister of National Defence and Minister of the Atlantic Canada Opportunities Agency. The Atlantic Innovation Fund is designed to increase leading edge research and development (R&D) in Atlantic Canadian research facilities, leading to the launch of new ideas, products, processes and services.

About the VacciMax(R) Platform

ImmunoVaccine Technologies Inc. (IVT) has developed a breakthrough vaccine-enhancement technology - the VacciMax(R) platform. It is comprised of a mixture of liposomes and adjuvants. The VacciMax(R) platform is able to stimulate an earlier, more powerful, long lasting immune response that could provide a new way to treat a wide range of diseases.

The opportunities for market applications and medical benefits for the VacciMax(R) platform are broad, and include prostate, breast, cervical, ovarian, colon and lung cancer treatments, as well as vaccines for pandemic influenza and other infectious diseases. http://www.immunovaccine.com


'/>"/>
SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.
2. National report calls for more research on health effects of wireless technologies
3. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
4. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
5. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
6. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
7. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
8. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
9. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies
10. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
11. BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens, Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched today the ... education institutions in Hong Kong to support teaching, learning and research. It is also ... of facilities in Hong Kong. , With an area of 620 square metres ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway Management, the ... with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence with a ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... Providing ... not understand the estate planning process, or where to even begin. “Now more than ... if you are to properly protect yourself and your family,” said attorney Lisa Edgar ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 /PRNewswire/ ... ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron Ehlen ... the signing of a three-year exclusive sales representation ... a dedicated sales team to introduce Imprimis, ophthalmic ... focused in 13 states in the U.S. Midwest. Precision ...
Breaking Medicine Technology: